Compounded GLP-1 medication and safety

What compounding is, how it is regulated, how to check a pharmacy's license, and how to tell a legitimate service from a gray-market one. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality.

9 articles · Compounded GLP-1 medications, explained

Compounded GLP-1 medications, explained

What compounded semaglutide and tirzepatide are, how they differ from brand-name products, and what to know before starting.

September 24, 2026 · 7 min read

Is online weight care legitimate? How telehealth prescribing works

Who is actually treating you when care happens through a website — licensure, independent practices, and when telehealth is the wrong tool.

September 15, 2026 · 6 min read

Is compounded semaglutide legal? How the rules work

Compounding is a regulated practice, but what may be compounded changes with FDA determinations. Here is the framework, and how to check where things stand now.

October 2, 2026 · 8 min read

Is compounded semaglutide safe? Risks and what to check

What changes when a GLP-1 is compounded rather than manufactured, which risks are real, and the specific things to check before you inject anything.

October 2, 2026 · 8 min read

503A vs 503B compounding pharmacies: the difference

Two sections of federal law, two kinds of compounding pharmacy, two oversight regimes. What separates them and why it matters for a prescription you receive.

October 2, 2026 · 6 min read

How to verify a compounding pharmacy's license

You can check the pharmacy that prepares your medication yourself, in a few minutes, using public registers. Here is exactly where to look and what to look for.

October 2, 2026 · 6 min read

What is added to compounded semaglutide, and why

Compounded GLP-1s are sometimes prepared with B12, glycine or other additions. What they are for, what the evidence says, and what to ask your pharmacy.

October 2, 2026 · 6 min read

How to spot counterfeit GLP-1 medication

Counterfeit GLP-1 products have reached patients through unauthorised sellers. What the warning signs are, what to check, and what to do if you suspect one.

October 2, 2026 · 7 min read

Research-use peptides and gray-market GLP-1s: the risks

Vials sold as research chemicals are not medicine, and that label is the seller's legal cover. What you take on, and why dosing is the biggest risk.

October 2, 2026 · 7 min read

Ready to see if you qualify?

It takes about two minutes — no cost, no obligation.

Get started